UNSPSC 85502121: Supplement right subclavian artery with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right subclavian artery with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03U337Z

UNSPSC 85502121 Supplement right subclavian artery with autologous tissue substitute, percutaneous approach is a Commodity code that does not align with the recent state and local contract opportunities posted against it. The source records show that this code has been applied to medical service solicitations — independent medical evaluations for disability pension determinations, surgical benefit carve-out programs, occupational medical surveillance, youth detention medical services, pharmacy benefit management, and temporary health professional staffing — none of which involve surgical intervention on the subclavian artery or autologous tissue grafting. The mismatch suggests either a tagging error in the underlying procurement systems or a fundamental misalignment between the UNSPSC taxonomy as applied and the clinical services actually being procured.

The recent opportunities do reveal what state and local governments are actually buying in the medical services space: the City of Phoenix Retirement Office seeks independent medical evaluation services for disability benefit determinations ($750,000 over five years, RFP RTMRFP26001, due October 16, 2026); the City of Long Beach is procuring surgical procedure carve-out benefits through Centers of Excellence networks (RFP HR26753, due October 7, 2026); the Washington State Department of Transportation seeks occupational medical surveillance by board-certified occupational physicians across 14 locations (RFP RFP20260825, due October 9, 2026); and the County of Santa Clara Health System is qualifying vendors for temporary ancillary health professional staffing across multiple specialties (RFQ RFSQHHSFY270052, due October 7, 2026). Given the code's nominal scope and the absence of any subclavian artery or autologous tissue work in the recent record, this code shows little relevant procurement activity for business development purposes at present.